{"id":241517,"date":"2020-12-31T10:40:35","date_gmt":"2020-12-31T05:10:35","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=241517"},"modified":"2020-12-31T10:38:22","modified_gmt":"2020-12-31T05:08:22","slug":"subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/","title":{"rendered":"Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech"},"content":{"rendered":"<p style=\"text-align: justify;\">The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation (CDSCO) to consider the Emergency Use Authorisation (EUA) request of Pfizer, Serum Institute of India (SII) and Bharat Biotech Pvt. Ltd.<\/p>\n<p style=\"text-align: justify;\">Further time was requested on behalf of Pfizer. The additional data and information presented by SII and Bharat Biotech Pvt. Ltd. was perused and analysed by the SEC.<\/p>\n<p style=\"text-align: justify;\">The analysis of the additional data and information is going on. SEC will convene again on 01-01- 2021.<\/p>\n<hr \/>\n<p><strong>Ministry of Health and Family Welfare<\/strong><\/p>\n<p style=\"text-align: right;\"><strong>[Press Release dt. 30-12-2020]<\/strong><\/p>\n<p><strong>[Source: PIB]<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation (CDSCO) to consider the Emergency Use Authorisation (EUA) request of <\/p>\n","protected":false},"author":8808,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1188,2],"tags":[44663,41821,36837,28914,44664],"class_list":["post-241517","post","type-post","status-publish","format-standard","hentry","category-hot_off_the_press","category-news","tag-bharat-biotech","tag-mohfw","tag-pfizer","tag-sec","tag-subject-expert-committee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.4 (Yoast SEO v26.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech | SCC Times<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech\" \/>\n<meta property=\"og:description\" content=\"The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation (CDSCO) to consider the Emergency Use Authorisation (EUA) request of\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-31T05:10:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2019\/09\/Ministry-of-Health-and-Family-Welfare.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1330\" \/>\n\t<meta property=\"og:image:height\" content=\"887\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bhumika Indulia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bhumika Indulia\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/\",\"name\":\"Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"datePublished\":\"2020-12-31T05:10:35+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a\",\"name\":\"Bhumika Indulia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg\",\"caption\":\"Bhumika Indulia\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech | SCC Times","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/","og_locale":"en_US","og_type":"article","og_title":"Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech","og_description":"The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation (CDSCO) to consider the Emergency Use Authorisation (EUA) request of","og_url":"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2020-12-31T05:10:35+00:00","og_image":[{"width":1330,"height":887,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2019\/09\/Ministry-of-Health-and-Family-Welfare.jpg","type":"image\/jpeg"}],"author":"Bhumika Indulia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Bhumika Indulia"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/","url":"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/","name":"Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"datePublished":"2020-12-31T05:10:35+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a"},"breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2020\/12\/31\/subject-expert-committee-sec-meets-to-consider-emergency-use-authorisation-request-from-pfizer-sii-and-bharat-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a","name":"Bhumika Indulia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg","caption":"Bhumika Indulia"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":280792,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/01\/02\/karnataka-high-court-refuses-entertain-writ-petition-bharat-biotech-private-contract-united-brothers-healthcare-services-for-supply-of-covaxin-doses-legal-news\/","url_meta":{"origin":241517,"position":0},"title":"Karnataka HC refuses to entertain writ petition against Bharat Biotech vis-\u00e0-vis a private contract with United Brothers Healthcare Services for supply of Covaxin doses","author":"Editor","date":"January 2, 2023","format":false,"excerpt":"Karnataka High Court observed that merely because Covaxin is being taken by public, it will not make a private contract enforceable or justiciable in the Courts of law, which are pre-dominantly meant for public law remedy.","rel":"","context":"In &quot;Case Briefs&quot;","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Karnataka High Court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/12\/MicrosoftTeams-image-424.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":250218,"url":"https:\/\/www.scconline.com\/blog\/post\/2021\/06\/23\/covid-19-vaccine\/","url_meta":{"origin":241517,"position":1},"title":"Ramping up production of Covid-19 vaccine and its interplay with patent law","author":"Editor","date":"June 23, 2021","format":false,"excerpt":"by Akber Ahmad\u2020 and Maria Fatima\u2020\u2020 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0","rel":"","context":"In &quot;Op Eds&quot;","block_context":{"text":"Op Eds","link":"https:\/\/www.scconline.com\/blog\/post\/category\/op-ed\/legal-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/06\/MicrosoftTeams-image-16.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/06\/MicrosoftTeams-image-16.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/06\/MicrosoftTeams-image-16.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/06\/MicrosoftTeams-image-16.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/06\/MicrosoftTeams-image-16.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":248030,"url":"https:\/\/www.scconline.com\/blog\/post\/2021\/05\/10\/covid-19-mad-hc-why-are-you-not-reviving-govt-vaccine-institutes-and-oxygen-plants-notice-to-govt-as-india-faces-vaccine-and-oxygen-shortage\/","url_meta":{"origin":241517,"position":2},"title":"[COVID-19] Mad HC| Why are you not reviving Govt. Vaccine Institutes and Oxygen Plants? Notice to Govt as India faces vaccine and oxygen shortage","author":"Prachi Bhardwaj","date":"May 10, 2021","format":false,"excerpt":"BHEL, Trichy, is having the facility of Oxygen production with three Oxygen plants, having capacity of 140 metric cube per hour, but, those plants are shut down since 2003. A dedicated Integrated Vaccine Complex (IVC) has been established at Chengalpattu in the year 2012, with international standards, which is having\u2026","rel":"","context":"In &quot;Case Briefs&quot;","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":220754,"url":"https:\/\/www.scconline.com\/blog\/post\/2019\/10\/11\/ncdrc-hepatitis-b-vaccine-revac-b-manufactured-by-bharat-biotech-held-not-hazardous-no-proof-of-defect-or-sub-standard-quality-found\/","url_meta":{"origin":241517,"position":3},"title":"NCDRC | Hepatitis-B vaccine &#8216;Revac-B&#8217; manufactured by Bharat Biotech held not hazardous, no proof of defect or sub-standard quality found","author":"Bhumika Indulia","date":"October 11, 2019","format":false,"excerpt":"National Consumer Disputes Redressal Commission (NCDRC): The Coram of Dr S.M. Kantikar (Presiding Member) and Dinesh Singh (Member), while deciding the present matter stated that, \u201cThe provisions of the Consumer Protection Act are in addition to and not in derogation of other laws in force.\u201d In the present case, Complainant\u2026","rel":"","context":"In &quot;Case Briefs&quot;","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"National Consumer Disputes Redressal Commission","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2018\/08\/NCDRC_.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2018\/08\/NCDRC_.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2018\/08\/NCDRC_.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2018\/08\/NCDRC_.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2018\/08\/NCDRC_.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":273735,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/09\/15\/central-information-commission-central-public-information-officer-section-20-of-the-right-to-information-act-2005-world-health-organisation-section-18-rti-act-covaxin-united-nations-bharat-bi\/","url_meta":{"origin":241517,"position":4},"title":"RTI on WHO&#8217;s suspension of Covaxin procurement| &#8216;CPIO&#8217;s reply incorrect, vague and mindlessly prepared&#8217;; CIC issues show cause notice","author":"Editor","date":"September 15, 2022","format":false,"excerpt":"Central Information Commission: In a complaint for an action against the Central Public Information Officer (CPIO) for willfully misleading and furnishing false information to the appellant, the Information Commissioner Heeralal Samariya, observed that the initial reply provided by the CPIO was incorrect, vague and mindlessly prepared and directed him to\u2026","rel":"","context":"In &quot;Case Briefs&quot;","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Central Information Commission","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/09\/Central-Information-Commission-1-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/09\/Central-Information-Commission-1-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/09\/Central-Information-Commission-1-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/09\/Central-Information-Commission-1-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/09\/Central-Information-Commission-1-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":66051,"url":"https:\/\/www.scconline.com\/blog\/post\/2016\/09\/02\/benefit-of-safe-harbor-provision-can-be-granted-only-to-divisional-patent-applications-and-not-to-continuation-in-part-applications\/","url_meta":{"origin":241517,"position":5},"title":"Benefit of &#8216;safe harbor&#8217; provision can be granted only to divisional patent applications and not to &#8216;continuation in part&#8217; applications","author":"Saba","date":"September 2, 2016","format":false,"excerpt":"United States Court of Appeals for the Federal Circuit: Chief Judge Prost, Bryson and Hughes, Circuit Judges ruled on a case involving patent protection of a product by Pfizer Asia Pacific (used as Pfizer ahead) used for the treatment of pain and inflammation without the harmful side effects associated with\u2026","rel":"","context":"In &quot;Case Briefs&quot;","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/09\/US-Court-of-Appeals-for-Federal-Circuit.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/09\/US-Court-of-Appeals-for-Federal-Circuit.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/09\/US-Court-of-Appeals-for-Federal-Circuit.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/09\/US-Court-of-Appeals-for-Federal-Circuit.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/09\/US-Court-of-Appeals-for-Federal-Circuit.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/241517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/8808"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=241517"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/241517\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=241517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=241517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=241517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}